nodes	percent_of_prediction	percent_of_DWPC	metapath
Agomelatine—CYP2C9—brain cancer	0.794	1	CbGaD
Agomelatine—CYP1A2—Carmustine—brain cancer	0.0395	0.771	CbGbCtD
Agomelatine—HTR2C—choroid plexus—brain cancer	0.0166	0.321	CbGeAlD
Agomelatine—CYP1A2—Etoposide—brain cancer	0.0117	0.229	CbGbCtD
Agomelatine—HTR2C—telencephalic ventricle—brain cancer	0.00487	0.0942	CbGeAlD
Agomelatine—MTNR1A—telencephalon—brain cancer	0.00478	0.0924	CbGeAlD
Agomelatine—MTNR1B—head—brain cancer	0.00377	0.0727	CbGeAlD
Agomelatine—HTR2C—ganglion—brain cancer	0.00303	0.0586	CbGeAlD
Agomelatine—MTNR1A—head—brain cancer	0.00298	0.0575	CbGeAlD
Agomelatine—MTNR1A—central nervous system—brain cancer	0.00272	0.0525	CbGeAlD
Agomelatine—MTNR1A—brain—brain cancer	0.00216	0.0417	CbGeAlD
Agomelatine—Nightmare—Procarbazine—brain cancer	0.00182	0.0248	CcSEcCtD
Agomelatine—HTR2C—brainstem—brain cancer	0.00132	0.0255	CbGeAlD
Agomelatine—Naproxen—CYP2C9—brain cancer	0.0013	0.374	CrCbGaD
Agomelatine—Infection—Carboplatin—brain cancer	0.0012	0.0164	CcSEcCtD
Agomelatine—Hepatic failure—Hydroxyurea—brain cancer	0.00118	0.016	CcSEcCtD
Agomelatine—HTR2C—telencephalon—brain cancer	0.00117	0.0226	CbGeAlD
Agomelatine—Phosphatase alkaline increased—Temozolomide—brain cancer	0.00114	0.0155	CcSEcCtD
Agomelatine—Melatonin—CYP2C9—brain cancer	0.00112	0.322	CrCbGaD
Agomelatine—HTR2B—telencephalon—brain cancer	0.0011	0.0212	CbGeAlD
Agomelatine—Indomethacin—CYP2C9—brain cancer	0.00105	0.303	CrCbGaD
Agomelatine—Infection—Lomustine—brain cancer	0.00105	0.0143	CcSEcCtD
Agomelatine—Jaundice—Procarbazine—brain cancer	0.00103	0.014	CcSEcCtD
Agomelatine—Face oedema—Hydroxyurea—brain cancer	0.00102	0.0139	CcSEcCtD
Agomelatine—Blood alkaline phosphatase increased—Temozolomide—brain cancer	0.000951	0.0129	CcSEcCtD
Agomelatine—Hallucination—Procarbazine—brain cancer	0.000942	0.0128	CcSEcCtD
Agomelatine—Hepatic failure—Temozolomide—brain cancer	0.00092	0.0125	CcSEcCtD
Agomelatine—HTR2C—medulla oblongata—brain cancer	0.00092	0.0178	CbGeAlD
Agomelatine—Phosphatase alkaline increased—Etoposide—brain cancer	0.000912	0.0124	CcSEcCtD
Agomelatine—HTR2C—midbrain—brain cancer	0.000841	0.0162	CbGeAlD
Agomelatine—Weight increased—Hydroxyurea—brain cancer	0.000833	0.0113	CcSEcCtD
Agomelatine—Face oedema—Carmustine—brain cancer	0.000826	0.0112	CcSEcCtD
Agomelatine—HTR2C—spinal cord—brain cancer	0.00082	0.0158	CbGeAlD
Agomelatine—Infestation NOS—Hydroxyurea—brain cancer	0.000816	0.0111	CcSEcCtD
Agomelatine—Infestation—Hydroxyurea—brain cancer	0.000816	0.0111	CcSEcCtD
Agomelatine—Face oedema—Temozolomide—brain cancer	0.000798	0.0109	CcSEcCtD
Agomelatine—Tremor—Procarbazine—brain cancer	0.000772	0.0105	CcSEcCtD
Agomelatine—Hepatobiliary disease—Hydroxyurea—brain cancer	0.000772	0.0105	CcSEcCtD
Agomelatine—Blood alkaline phosphatase increased—Etoposide—brain cancer	0.000761	0.0104	CcSEcCtD
Agomelatine—HTR2C—head—brain cancer	0.000729	0.0141	CbGeAlD
Agomelatine—Hallucination—Hydroxyurea—brain cancer	0.000729	0.00992	CcSEcCtD
Agomelatine—Anxiety—Procarbazine—brain cancer	0.000699	0.00951	CcSEcCtD
Agomelatine—Dry mouth—Procarbazine—brain cancer	0.000686	0.00934	CcSEcCtD
Agomelatine—HTR2B—head—brain cancer	0.000685	0.0132	CbGeAlD
Agomelatine—Vomiting—Lomustine—brain cancer	0.000673	0.00916	CcSEcCtD
Agomelatine—Infection—Procarbazine—brain cancer	0.000668	0.00909	CcSEcCtD
Agomelatine—HTR2C—central nervous system—brain cancer	0.000665	0.0129	CbGeAlD
Agomelatine—Depression—Carmustine—brain cancer	0.000658	0.00895	CcSEcCtD
Agomelatine—Weight increased—Temozolomide—brain cancer	0.000651	0.00885	CcSEcCtD
Agomelatine—Hyperhidrosis—Procarbazine—brain cancer	0.00065	0.00885	CcSEcCtD
Agomelatine—Weight decreased—Temozolomide—brain cancer	0.000647	0.0088	CcSEcCtD
Agomelatine—Infestation—Temozolomide—brain cancer	0.000637	0.00868	CcSEcCtD
Agomelatine—Infestation NOS—Temozolomide—brain cancer	0.000637	0.00868	CcSEcCtD
Agomelatine—Depression—Temozolomide—brain cancer	0.000636	0.00865	CcSEcCtD
Agomelatine—Nausea—Lomustine—brain cancer	0.000629	0.00856	CcSEcCtD
Agomelatine—HTR2B—central nervous system—brain cancer	0.000625	0.0121	CbGeAlD
Agomelatine—Insomnia—Procarbazine—brain cancer	0.000608	0.00828	CcSEcCtD
Agomelatine—Paraesthesia—Procarbazine—brain cancer	0.000604	0.00822	CcSEcCtD
Agomelatine—Hepatobiliary disease—Temozolomide—brain cancer	0.000603	0.0082	CcSEcCtD
Agomelatine—Somnolence—Procarbazine—brain cancer	0.000598	0.00814	CcSEcCtD
Agomelatine—Hallucination—Carmustine—brain cancer	0.000589	0.00802	CcSEcCtD
Agomelatine—Connective tissue disorder—Carmustine—brain cancer	0.000582	0.00792	CcSEcCtD
Agomelatine—Fatigue—Procarbazine—brain cancer	0.00058	0.00789	CcSEcCtD
Agomelatine—Constipation—Procarbazine—brain cancer	0.000575	0.00783	CcSEcCtD
Agomelatine—Hepatitis—Temozolomide—brain cancer	0.000572	0.00779	CcSEcCtD
Agomelatine—Hallucination—Temozolomide—brain cancer	0.000569	0.00775	CcSEcCtD
Agomelatine—Connective tissue disorder—Temozolomide—brain cancer	0.000562	0.00765	CcSEcCtD
Agomelatine—Eye disorder—Carmustine—brain cancer	0.000553	0.00753	CcSEcCtD
Agomelatine—Gastrointestinal pain—Procarbazine—brain cancer	0.00055	0.00748	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000539	0.00734	CcSEcCtD
Agomelatine—Eye disorder—Temozolomide—brain cancer	0.000535	0.00728	CcSEcCtD
Agomelatine—Urticaria—Procarbazine—brain cancer	0.000534	0.00727	CcSEcCtD
Agomelatine—Tinnitus—Temozolomide—brain cancer	0.000533	0.00726	CcSEcCtD
Agomelatine—Abdominal pain—Procarbazine—brain cancer	0.000532	0.00723	CcSEcCtD
Agomelatine—HTR2C—brain—brain cancer	0.000528	0.0102	CbGeAlD
Agomelatine—Mental disorder—Carmustine—brain cancer	0.000519	0.00706	CcSEcCtD
Agomelatine—Infection—Hydroxyurea—brain cancer	0.000517	0.00704	CcSEcCtD
Agomelatine—Nervous system disorder—Hydroxyurea—brain cancer	0.00051	0.00695	CcSEcCtD
Agomelatine—Infestation NOS—Etoposide—brain cancer	0.00051	0.00694	CcSEcCtD
Agomelatine—Infestation—Etoposide—brain cancer	0.00051	0.00694	CcSEcCtD
Agomelatine—Skin disorder—Hydroxyurea—brain cancer	0.000505	0.00688	CcSEcCtD
Agomelatine—Mental disorder—Temozolomide—brain cancer	0.000501	0.00682	CcSEcCtD
Agomelatine—Back pain—Carmustine—brain cancer	0.000499	0.00679	CcSEcCtD
Agomelatine—Jaundice—Etoposide—brain cancer	0.000497	0.00677	CcSEcCtD
Agomelatine—HTR2B—brain—brain cancer	0.000496	0.00959	CbGeAlD
Agomelatine—Vision blurred—Carmustine—brain cancer	0.000486	0.00661	CcSEcCtD
Agomelatine—Tremor—Carmustine—brain cancer	0.000483	0.00657	CcSEcCtD
Agomelatine—Asthenia—Procarbazine—brain cancer	0.000482	0.00657	CcSEcCtD
Agomelatine—Hepatobiliary disease—Etoposide—brain cancer	0.000482	0.00657	CcSEcCtD
Agomelatine—Back pain—Temozolomide—brain cancer	0.000482	0.00656	CcSEcCtD
Agomelatine—Pruritus—Procarbazine—brain cancer	0.000476	0.00647	CcSEcCtD
Agomelatine—CYP1A2—endocrine gland—brain cancer	0.000474	0.00915	CbGeAlD
Agomelatine—Agitation—Carmustine—brain cancer	0.000474	0.00645	CcSEcCtD
Agomelatine—Vision blurred—Temozolomide—brain cancer	0.000469	0.00639	CcSEcCtD
Agomelatine—Tremor—Temozolomide—brain cancer	0.000467	0.00635	CcSEcCtD
Agomelatine—Somnolence—Hydroxyurea—brain cancer	0.000463	0.0063	CcSEcCtD
Agomelatine—Diarrhoea—Procarbazine—brain cancer	0.00046	0.00626	CcSEcCtD
Agomelatine—Dyspepsia—Hydroxyurea—brain cancer	0.000458	0.00623	CcSEcCtD
Agomelatine—Agitation—Temozolomide—brain cancer	0.000458	0.00623	CcSEcCtD
Agomelatine—Angioedema—Temozolomide—brain cancer	0.000455	0.00619	CcSEcCtD
Agomelatine—CYP2C9—endocrine gland—brain cancer	0.00045	0.00869	CbGeAlD
Agomelatine—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000449	0.00611	CcSEcCtD
Agomelatine—Fatigue—Hydroxyurea—brain cancer	0.000449	0.00611	CcSEcCtD
Agomelatine—Vertigo—Temozolomide—brain cancer	0.000448	0.00609	CcSEcCtD
Agomelatine—Constipation—Hydroxyurea—brain cancer	0.000445	0.00606	CcSEcCtD
Agomelatine—Dizziness—Procarbazine—brain cancer	0.000445	0.00605	CcSEcCtD
Agomelatine—Anxiety—Carmustine—brain cancer	0.000437	0.00595	CcSEcCtD
Agomelatine—Eye disorder—Etoposide—brain cancer	0.000428	0.00582	CcSEcCtD
Agomelatine—Vomiting—Procarbazine—brain cancer	0.000427	0.00582	CcSEcCtD
Agomelatine—Anxiety—Temozolomide—brain cancer	0.000423	0.00575	CcSEcCtD
Agomelatine—Headache—Procarbazine—brain cancer	0.000421	0.00573	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000421	0.00573	CcSEcCtD
Agomelatine—Infection—Carmustine—brain cancer	0.000418	0.00569	CcSEcCtD
Agomelatine—Dry mouth—Temozolomide—brain cancer	0.000415	0.00564	CcSEcCtD
Agomelatine—Infection—Temozolomide—brain cancer	0.000404	0.0055	CcSEcCtD
Agomelatine—Nausea—Procarbazine—brain cancer	0.000399	0.00544	CcSEcCtD
Agomelatine—Nervous system disorder—Temozolomide—brain cancer	0.000399	0.00543	CcSEcCtD
Agomelatine—Skin disorder—Temozolomide—brain cancer	0.000395	0.00537	CcSEcCtD
Agomelatine—Hyperhidrosis—Temozolomide—brain cancer	0.000393	0.00535	CcSEcCtD
Agomelatine—Back pain—Etoposide—brain cancer	0.000386	0.00525	CcSEcCtD
Agomelatine—Insomnia—Carmustine—brain cancer	0.00038	0.00518	CcSEcCtD
Agomelatine—Paraesthesia—Carmustine—brain cancer	0.000378	0.00514	CcSEcCtD
Agomelatine—Somnolence—Carmustine—brain cancer	0.000374	0.00509	CcSEcCtD
Agomelatine—Asthenia—Hydroxyurea—brain cancer	0.000373	0.00508	CcSEcCtD
Agomelatine—Insomnia—Temozolomide—brain cancer	0.000368	0.005	CcSEcCtD
Agomelatine—Paraesthesia—Temozolomide—brain cancer	0.000365	0.00497	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Carmustine—brain cancer	0.000363	0.00494	CcSEcCtD
Agomelatine—Somnolence—Temozolomide—brain cancer	0.000361	0.00492	CcSEcCtD
Agomelatine—Constipation—Carmustine—brain cancer	0.00036	0.0049	CcSEcCtD
Agomelatine—Vertigo—Etoposide—brain cancer	0.000358	0.00487	CcSEcCtD
Agomelatine—Dyspepsia—Temozolomide—brain cancer	0.000358	0.00487	CcSEcCtD
Agomelatine—Diarrhoea—Hydroxyurea—brain cancer	0.000356	0.00485	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Temozolomide—brain cancer	0.000351	0.00478	CcSEcCtD
Agomelatine—Fatigue—Temozolomide—brain cancer	0.00035	0.00477	CcSEcCtD
Agomelatine—Constipation—Temozolomide—brain cancer	0.000348	0.00473	CcSEcCtD
Agomelatine—Dizziness—Hydroxyurea—brain cancer	0.000344	0.00468	CcSEcCtD
Agomelatine—Gastrointestinal pain—Carmustine—brain cancer	0.000344	0.00468	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000337	0.00459	CcSEcCtD
Agomelatine—Abdominal pain—Carmustine—brain cancer	0.000333	0.00453	CcSEcCtD
Agomelatine—Gastrointestinal pain—Temozolomide—brain cancer	0.000332	0.00452	CcSEcCtD
Agomelatine—Vomiting—Hydroxyurea—brain cancer	0.000331	0.0045	CcSEcCtD
Agomelatine—Headache—Hydroxyurea—brain cancer	0.000326	0.00444	CcSEcCtD
Agomelatine—Infection—Etoposide—brain cancer	0.000323	0.0044	CcSEcCtD
Agomelatine—Urticaria—Temozolomide—brain cancer	0.000323	0.0044	CcSEcCtD
Agomelatine—Abdominal pain—Temozolomide—brain cancer	0.000321	0.00437	CcSEcCtD
Agomelatine—Skin disorder—Etoposide—brain cancer	0.000316	0.0043	CcSEcCtD
Agomelatine—Hyperhidrosis—Etoposide—brain cancer	0.000314	0.00428	CcSEcCtD
Agomelatine—Nausea—Hydroxyurea—brain cancer	0.000309	0.00421	CcSEcCtD
Agomelatine—Asthenia—Carmustine—brain cancer	0.000302	0.00411	CcSEcCtD
Agomelatine—Paraesthesia—Etoposide—brain cancer	0.000292	0.00398	CcSEcCtD
Agomelatine—Asthenia—Temozolomide—brain cancer	0.000292	0.00397	CcSEcCtD
Agomelatine—Somnolence—Etoposide—brain cancer	0.000289	0.00394	CcSEcCtD
Agomelatine—Diarrhoea—Carmustine—brain cancer	0.000288	0.00392	CcSEcCtD
Agomelatine—Pruritus—Temozolomide—brain cancer	0.000288	0.00391	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Etoposide—brain cancer	0.000281	0.00382	CcSEcCtD
Agomelatine—Fatigue—Etoposide—brain cancer	0.00028	0.00382	CcSEcCtD
Agomelatine—Dizziness—Carmustine—brain cancer	0.000278	0.00379	CcSEcCtD
Agomelatine—Constipation—Etoposide—brain cancer	0.000278	0.00379	CcSEcCtD
Agomelatine—Diarrhoea—Temozolomide—brain cancer	0.000278	0.00379	CcSEcCtD
Agomelatine—Dizziness—Temozolomide—brain cancer	0.000269	0.00366	CcSEcCtD
Agomelatine—Vomiting—Carmustine—brain cancer	0.000267	0.00364	CcSEcCtD
Agomelatine—Gastrointestinal pain—Etoposide—brain cancer	0.000266	0.00362	CcSEcCtD
Agomelatine—Headache—Carmustine—brain cancer	0.000264	0.00359	CcSEcCtD
Agomelatine—Vomiting—Temozolomide—brain cancer	0.000258	0.00352	CcSEcCtD
Agomelatine—Urticaria—Etoposide—brain cancer	0.000258	0.00352	CcSEcCtD
Agomelatine—Abdominal pain—Etoposide—brain cancer	0.000257	0.0035	CcSEcCtD
Agomelatine—Headache—Temozolomide—brain cancer	0.000255	0.00347	CcSEcCtD
Agomelatine—Nausea—Carmustine—brain cancer	0.00025	0.0034	CcSEcCtD
Agomelatine—Nausea—Temozolomide—brain cancer	0.000241	0.00329	CcSEcCtD
Agomelatine—Asthenia—Etoposide—brain cancer	0.000233	0.00318	CcSEcCtD
Agomelatine—Pruritus—Etoposide—brain cancer	0.00023	0.00313	CcSEcCtD
Agomelatine—MTNR1B—GPCR ligand binding—PTCH1—brain cancer	0.000224	0.00844	CbGpPWpGaD
Agomelatine—Diarrhoea—Etoposide—brain cancer	0.000223	0.00303	CcSEcCtD
Agomelatine—MTNR1B—Signaling Pathways—OR14C36—brain cancer	0.000216	0.00813	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—OR14C36—brain cancer	0.000216	0.00813	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—OR4C12—brain cancer	0.000216	0.00813	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—OR4C12—brain cancer	0.000216	0.00813	CbGpPWpGaD
Agomelatine—MTNR1A—Circadian rythm related genes—CDK4—brain cancer	0.000215	0.00812	CbGpPWpGaD
Agomelatine—MTNR1B—Circadian rythm related genes—CDK4—brain cancer	0.000215	0.00812	CbGpPWpGaD
Agomelatine—Dizziness—Etoposide—brain cancer	0.000215	0.00293	CcSEcCtD
Agomelatine—Vomiting—Etoposide—brain cancer	0.000207	0.00282	CcSEcCtD
Agomelatine—Headache—Etoposide—brain cancer	0.000204	0.00277	CcSEcCtD
Agomelatine—MTNR1A—GPCR downstream signaling—ABR—brain cancer	0.000203	0.00766	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—ABR—brain cancer	0.000203	0.00766	CbGpPWpGaD
Agomelatine—Nausea—Etoposide—brain cancer	0.000193	0.00263	CcSEcCtD
Agomelatine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000185	0.00698	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—ABR—brain cancer	0.000185	0.00696	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—ABR—brain cancer	0.000185	0.00696	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—DTX2—brain cancer	0.000183	0.00691	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—DTX2—brain cancer	0.000183	0.00691	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—PTCH2—brain cancer	0.000148	0.00558	CbGpPWpGaD
Agomelatine—HTR2B—G alpha (q) signalling events—TRPC6—brain cancer	0.000146	0.0055	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—PTCH2—brain cancer	0.000139	0.00524	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—PTCH2—brain cancer	0.000139	0.00524	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—HES5—brain cancer	0.000135	0.00507	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—HES5—brain cancer	0.000135	0.00507	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—STRADA—brain cancer	0.000131	0.00493	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—STRADA—brain cancer	0.000131	0.00493	CbGpPWpGaD
Agomelatine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—brain cancer	0.00013	0.00491	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—OR4C12—brain cancer	0.00013	0.00489	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—OR14C36—brain cancer	0.00013	0.00489	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—TRPC6—brain cancer	0.000129	0.00485	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—TRPC6—brain cancer	0.000129	0.00485	CbGpPWpGaD
Agomelatine—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	0.000122	0.0046	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—SHH—brain cancer	0.000121	0.00457	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—SHH—brain cancer	0.000121	0.00457	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—PTCH2—brain cancer	0.000119	0.0045	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—OR4C12—brain cancer	0.000118	0.00444	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—OR14C36—brain cancer	0.000118	0.00444	CbGpPWpGaD
Agomelatine—HTR2C—G alpha (q) signalling events—TRPC6—brain cancer	0.000118	0.00443	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—TRPC6—brain cancer	0.000117	0.00441	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—TRPC6—brain cancer	0.000117	0.00441	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—PTCH1—brain cancer	0.000115	0.00433	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—SMO—brain cancer	0.000115	0.00433	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—SMO—brain cancer	0.000115	0.00433	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—PTCH1—brain cancer	0.000115	0.00433	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—ABR—brain cancer	0.000109	0.00411	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—ABR—brain cancer	0.000109	0.00411	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—GLI2—brain cancer	0.000105	0.00397	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—GLI2—brain cancer	0.000105	0.00397	CbGpPWpGaD
Agomelatine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—brain cancer	0.000105	0.00397	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—OR4C12—brain cancer	0.000105	0.00395	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—OR14C36—brain cancer	0.000105	0.00395	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000101	0.00383	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—GLI1—brain cancer	9.9e-05	0.00373	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—GLI1—brain cancer	9.9e-05	0.00373	CbGpPWpGaD
Agomelatine—CYP1A2—Biological oxidations—CYP2C9—brain cancer	9.84e-05	0.00371	CbGpPWpGaD
Agomelatine—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	9.7e-05	0.00366	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—VAV1—brain cancer	9.64e-05	0.00364	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—VAV1—brain cancer	9.64e-05	0.00364	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—OR4C12—brain cancer	9.51e-05	0.00358	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—OR14C36—brain cancer	9.51e-05	0.00358	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—SUFU—brain cancer	9.39e-05	0.00354	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—SUFU—brain cancer	9.39e-05	0.00354	CbGpPWpGaD
Agomelatine—MTNR1B—Circadian rythm related genes—TP53—brain cancer	9.16e-05	0.00345	CbGpPWpGaD
Agomelatine—MTNR1A—Circadian rythm related genes—TP53—brain cancer	9.16e-05	0.00345	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—GFAP—brain cancer	9.05e-05	0.00341	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—GFAP—brain cancer	9.05e-05	0.00341	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—VAV1—brain cancer	8.75e-05	0.0033	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—VAV1—brain cancer	8.75e-05	0.0033	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—HEY1—brain cancer	8.58e-05	0.00324	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—HEY1—brain cancer	8.58e-05	0.00324	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—DLL1—brain cancer	8.42e-05	0.00317	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—DLL1—brain cancer	8.42e-05	0.00317	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—SHH—brain cancer	7.62e-05	0.00287	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—PTCH2—brain cancer	7.59e-05	0.00286	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—SMO—brain cancer	7.23e-05	0.00272	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—PTCH1—brain cancer	7.23e-05	0.00272	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—SHH—brain cancer	7.16e-05	0.0027	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—SHH—brain cancer	7.16e-05	0.0027	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—OR14C36—brain cancer	6.96e-05	0.00262	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—OR4C12—brain cancer	6.96e-05	0.00262	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—TRPC6—brain cancer	6.9e-05	0.0026	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—TRPC6—brain cancer	6.9e-05	0.0026	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—PTCH1—brain cancer	6.79e-05	0.00256	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—PTCH1—brain cancer	6.79e-05	0.00256	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—SMO—brain cancer	6.79e-05	0.00256	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—SMO—brain cancer	6.79e-05	0.00256	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—ABR—brain cancer	6.56e-05	0.00247	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—SHH—brain cancer	6.15e-05	0.00232	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—PTCH2—brain cancer	6.13e-05	0.00231	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—PIK3CG—brain cancer	6.12e-05	0.00231	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—PIK3CG—brain cancer	6.12e-05	0.00231	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—ABR—brain cancer	5.96e-05	0.00225	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—DTX2—brain cancer	5.92e-05	0.00223	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	5.85e-05	0.00221	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—SMO—brain cancer	5.83e-05	0.0022	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—PTCH1—brain cancer	5.83e-05	0.0022	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—OR4C12—brain cancer	5.62e-05	0.00212	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—OR14C36—brain cancer	5.62e-05	0.00212	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—PIK3CG—brain cancer	5.56e-05	0.0021	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—PIK3CG—brain cancer	5.56e-05	0.0021	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—NOTCH2—brain cancer	5.42e-05	0.00205	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—NOTCH2—brain cancer	5.42e-05	0.00205	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—ABR—brain cancer	5.29e-05	0.002	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	5.27e-05	0.00199	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—VAV1—brain cancer	5.17e-05	0.00195	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—VAV1—brain cancer	5.17e-05	0.00195	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—ABR—brain cancer	4.81e-05	0.00181	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—DTX2—brain cancer	4.77e-05	0.0018	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PTCH2—brain cancer	4.49e-05	0.00169	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	4.48e-05	0.00169	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—HES1—brain cancer	4.45e-05	0.00168	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—HES1—brain cancer	4.45e-05	0.00168	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—HES5—brain cancer	4.34e-05	0.00164	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—IL2—brain cancer	4.31e-05	0.00162	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—IL2—brain cancer	4.31e-05	0.00162	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—PDGFRA—brain cancer	4.23e-05	0.0016	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—PDGFRA—brain cancer	4.23e-05	0.0016	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—STRADA—brain cancer	4.22e-05	0.00159	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—TRPC6—brain cancer	4.15e-05	0.00157	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	4.12e-05	0.00155	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—SPP1—brain cancer	4.11e-05	0.00155	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—SPP1—brain cancer	4.11e-05	0.00155	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	4.03e-05	0.00152	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	4.03e-05	0.00152	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—SHH—brain cancer	3.91e-05	0.00147	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—IL2—brain cancer	3.91e-05	0.00147	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—IL2—brain cancer	3.91e-05	0.00147	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.78e-05	0.00142	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—TRPC6—brain cancer	3.77e-05	0.00142	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—IRS2—brain cancer	3.72e-05	0.0014	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—IRS2—brain cancer	3.72e-05	0.0014	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—SMO—brain cancer	3.71e-05	0.0014	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—PTCH1—brain cancer	3.71e-05	0.0014	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PTCH2—brain cancer	3.62e-05	0.00136	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—ABR—brain cancer	3.52e-05	0.00133	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—HES5—brain cancer	3.5e-05	0.00132	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—STRADA—brain cancer	3.4e-05	0.00128	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—GLI2—brain cancer	3.4e-05	0.00128	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—TRPC6—brain cancer	3.35e-05	0.00126	CbGpPWpGaD
Agomelatine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	3.34e-05	0.00126	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—PIK3CG—brain cancer	3.28e-05	0.00124	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—APC—brain cancer	3.28e-05	0.00124	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—PIK3CG—brain cancer	3.28e-05	0.00124	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—APC—brain cancer	3.28e-05	0.00124	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.23e-05	0.00122	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—GLI1—brain cancer	3.2e-05	0.00121	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—SHH—brain cancer	3.16e-05	0.00119	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—VAV1—brain cancer	3.11e-05	0.00117	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—TRPC6—brain cancer	3.04e-05	0.00115	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—SUFU—brain cancer	3.03e-05	0.00114	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—EGFR—brain cancer	2.99e-05	0.00113	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—EGFR—brain cancer	2.99e-05	0.00113	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—SMO—brain cancer	2.99e-05	0.00113	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—PTCH1—brain cancer	2.99e-05	0.00113	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—GFAP—brain cancer	2.92e-05	0.0011	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—ABR—brain cancer	2.84e-05	0.00107	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—VAV1—brain cancer	2.83e-05	0.00107	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—HEY1—brain cancer	2.77e-05	0.00104	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.76e-05	0.00104	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—GLI2—brain cancer	2.74e-05	0.00103	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—DLL1—brain cancer	2.72e-05	0.00102	CbGpPWpGaD
Agomelatine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	2.69e-05	0.00102	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—GLI1—brain cancer	2.58e-05	0.000972	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—RELA—brain cancer	2.57e-05	0.000967	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—RELA—brain cancer	2.57e-05	0.000967	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—ERBB2—brain cancer	2.55e-05	0.000961	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—ERBB2—brain cancer	2.55e-05	0.000961	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—VAV1—brain cancer	2.51e-05	0.000947	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—SUFU—brain cancer	2.44e-05	0.000922	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—GFAP—brain cancer	2.36e-05	0.000889	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—IL2—brain cancer	2.31e-05	0.000871	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—IL2—brain cancer	2.31e-05	0.000871	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—SHH—brain cancer	2.31e-05	0.000871	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—VAV1—brain cancer	2.28e-05	0.00086	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—CCND1—brain cancer	2.25e-05	0.000849	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—CCND1—brain cancer	2.25e-05	0.000849	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—HEY1—brain cancer	2.24e-05	0.000843	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—CTNNB1—brain cancer	2.23e-05	0.000841	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—CTNNB1—brain cancer	2.23e-05	0.000841	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—TRPC6—brain cancer	2.23e-05	0.00084	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—DLL1—brain cancer	2.19e-05	0.000827	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PTCH1—brain cancer	2.19e-05	0.000826	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—SMO—brain cancer	2.19e-05	0.000826	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—PIK3CG—brain cancer	1.98e-05	0.000745	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—VEGFA—brain cancer	1.96e-05	0.00074	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—VEGFA—brain cancer	1.96e-05	0.00074	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—STAT3—brain cancer	1.94e-05	0.000733	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—STAT3—brain cancer	1.94e-05	0.000733	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—SHH—brain cancer	1.86e-05	0.000703	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—MYC—brain cancer	1.81e-05	0.000681	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—MYC—brain cancer	1.81e-05	0.000681	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—TRPC6—brain cancer	1.8e-05	0.000678	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—PIK3CG—brain cancer	1.79e-05	0.000677	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—EGFR—brain cancer	1.77e-05	0.000666	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—EGFR—brain cancer	1.77e-05	0.000666	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—SMO—brain cancer	1.77e-05	0.000666	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PTCH1—brain cancer	1.77e-05	0.000666	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—NOTCH2—brain cancer	1.75e-05	0.00066	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CYP2C9—brain cancer	1.68e-05	0.000634	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—BSG—brain cancer	1.67e-05	0.000631	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—VAV1—brain cancer	1.67e-05	0.00063	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—PIK3CG—brain cancer	1.59e-05	0.000601	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—TP53—brain cancer	1.48e-05	0.00056	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—TP53—brain cancer	1.48e-05	0.00056	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—PIK3CG—brain cancer	1.45e-05	0.000546	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—IDH1—brain cancer	1.44e-05	0.000543	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—HES1—brain cancer	1.44e-05	0.000541	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—BSG—brain cancer	1.43e-05	0.000539	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NOTCH2—brain cancer	1.41e-05	0.000533	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—IL2—brain cancer	1.39e-05	0.000524	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PDGFRA—brain cancer	1.37e-05	0.000515	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—VAV1—brain cancer	1.35e-05	0.000508	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—SPP1—brain cancer	1.33e-05	0.0005	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—IL2—brain cancer	1.26e-05	0.000476	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—IDH1—brain cancer	1.23e-05	0.000464	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IRS2—brain cancer	1.2e-05	0.000453	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.17e-05	0.000442	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—HES1—brain cancer	1.16e-05	0.000437	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ENO2—brain cancer	1.14e-05	0.000429	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—IL2—brain cancer	1.12e-05	0.000423	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PDGFRA—brain cancer	1.1e-05	0.000416	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—SPP1—brain cancer	1.07e-05	0.000404	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PIK3CG—brain cancer	1.06e-05	0.0004	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—APC—brain cancer	1.06e-05	0.0004	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—IL2—brain cancer	1.02e-05	0.000384	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1e-05	0.000378	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ENO2—brain cancer	9.72e-06	0.000367	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IRS2—brain cancer	9.68e-06	0.000365	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—EGFR—brain cancer	9.66e-06	0.000364	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—APC—brain cancer	8.55e-06	0.000322	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PIK3CG—brain cancer	8.55e-06	0.000322	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—RELA—brain cancer	8.28e-06	0.000312	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—ERBB2—brain cancer	8.23e-06	0.00031	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—EGFR—brain cancer	7.79e-06	0.000294	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IL2—brain cancer	7.46e-06	0.000281	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CCND1—brain cancer	7.27e-06	0.000274	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CTNNB1—brain cancer	7.2e-06	0.000272	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—RELA—brain cancer	6.68e-06	0.000252	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—ERBB2—brain cancer	6.64e-06	0.00025	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—VEGFA—brain cancer	6.34e-06	0.000239	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—STAT3—brain cancer	6.28e-06	0.000237	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IL2—brain cancer	6.02e-06	0.000227	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CCND1—brain cancer	5.87e-06	0.000221	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—MYC—brain cancer	5.83e-06	0.00022	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CTNNB1—brain cancer	5.81e-06	0.000219	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—EGFR—brain cancer	5.7e-06	0.000215	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PIK3CG—brain cancer	5.22e-06	0.000197	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—VEGFA—brain cancer	5.11e-06	0.000193	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—STAT3—brain cancer	5.06e-06	0.000191	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—TP53—brain cancer	4.79e-06	0.000181	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—MYC—brain cancer	4.71e-06	0.000177	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—EGFR—brain cancer	4.6e-06	0.000174	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PIK3CG—brain cancer	4.46e-06	0.000168	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—TP53—brain cancer	3.86e-06	0.000146	CbGpPWpGaD
